Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: Prospective study

Spine

Volumn 37, Issue 23, 2012, Pages

  Ohtori, Seiji ^a   Inoue, Gen ^a   Orita, Sumihisa ^a   Yamauchi, Kazuyo ^a   Eguchi, Yawara ^a   Ochiai, Nobuyasu ^a   Kishida, Shunji ^a   Kuniyoshi, Kazuki ^a   Aoki, Yasuchika ^a   Nakamura, Junichi ^a   Ishikawa, Tetsuhiro ^a   Miyagi, Masayuki ^a   Kamoda, Hiroto ^a   Suzuki, Miyako ^a   Kubota, Gou ^a   Sakuma, Yoshihiro ^a   Oikawa, Yasuhiro ^a   Inage, Kazuhide ^a   Sainoh, Takeshi ^a   Takaso, Masashi ^a   Ozawa, Tomoyuki ^a   Takahashi, Kazuhisa ^a   Toyone, Tomoaki ^a   more..

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Lumbar spine; Osteoporosis; Posterolateral fusion; Postmenopausal; Teriparatide

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARATHYROID HORMONE[1-34]; RISEDRONIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BONE GRAFT; BONE PAIN; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; LOW BACK PAIN; LUMBAR POSTEROLATERAL FUSION; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; POSTERIOR SPINE FUSION; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; SCORING SYSTEM; SPINAL CORD DECOMPRESSION; SPINE RADIOGRAPHY; SPONDYLOLISTHESIS; SURGICAL PATIENT;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE TRANSPLANTATION; DECOMPRESSION, SURGICAL; DRUG ADMINISTRATION SCHEDULE; ETIDRONIC ACID; FEMALE; HUMANS; ILIUM; INJECTIONS, SUBCUTANEOUS; JAPAN; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES; SPINAL FUSION; TERIPARATIDE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84868634603     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31826ca2a8     Document Type: Article

References (21)

1. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989 ; 3: 192-5.
2. Kurz LT, Garfi n SR, Booth RE Jr. Harvesting autogenous iliac bone grafts: a review of complications and techniques. Spine 1989 ; 14: 1324-31.
3. Fernyhough JC, Schimandle JJ, Weigel MC, et al. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine 1992 ; 17: 1474-80.
4. Hu R, Hearn T, Yang J. Bone graft harvest site as a determinant of iliac crest strength. Clin Orthop 1995 ; 310: 252-6.
5. Sasso RC, LeHuec JC, Shaffrey C. Spine Interbody Research Group. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. J Spinal Disord Tech 2005; 18: S77-81.
6. Miyazaki M, Tsumura H, Wang JC, et al. An update on bone substitutes for spinal fusion. Eur Spine J 2009 ; 18: 783-99.
7. McGovern SC, Fong W, Wang JC. Can bone morphogenetic protein binding peptide increase effi ciency of bone formation ?Spine 2010 ; 35: 1655-9.
8. Li G, Patil CG, Lad SP, et al. Effects of age and comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients. Spine 2008 ; 33: 1250-5.
9. Kim YJ, Bridwell KH, Lenke LG, et al. Pseudoarthrosis in long adult spinal deformity instrumentation and fusion to the sacrum: prevalence and risk factor analysis of 144 cases. Spine 2006 ;31: 2329-36.
10. Dempster DW, Cosman F, Kurland ES, et al. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001 ; 16: 1846-53.
11. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001 ; 344: 1434-41.
12. Lehman RA Jr, Dmitriev AE, Cardoso MJ, et al. Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model. Spine 2010 ; 35: 146-52.
13. O'Loughlin PF, Cunningham ME, Bukata SV, et al. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine 2009 ; 34: 121-30.
14. Abe Y, Takahata M, Ito M, et al. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model. Bone 2007 ; 41: 775-85.
15. Orimo H, Hayashi Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001 ; 19: 331-7.
16. Aspenberg P, Genant HK, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010 ; 25: 404-14.
17. Huang RC, Khan SN, Sandhu HS, et al. Alendronate inhibits spine fusion in a rat model. Spine 2005 ; 30: 2516-22.
18. Bransford R, Goergens E, Briody J, et al. Effect of zoledronic acid in an L6-L7 rabbit spine fusion model. Eur Spine J 2007 ; 16: 557-62.
19. Nagahama K, Kanayama M, Togawa D, et al. Does alendronate disturb the healing process of posterior lumbar interbody fusion?A prospective randomized trial. J Neurosurg Spine 2011 ; 14: 500-7.
20. Fischgrund JS, Mackay M, Herkowitz HN, et al. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine 1997 ; 22: 2807-12.
21. Herkowitz HN, Kurz LT. Degenerative lumbar spondylolisthesis with spinal stenosis. J Bone Joint Surg Am 1991 ; 73: 802-7.